Related Experiment Video
Updated: Aug 29, 2025

Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Current Understanding of Asthma Pathogenesis and Biomarkers
Nazia Habib1, Muhammad Asghar Pasha2, Dale D Tang1
1Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA.
Asthma involves diverse mechanisms, including T helper type 2 (Th2) inflammation and inflammation-independent pathways. Identifying specific biomarkers is crucial for accurate asthma diagnosis and treatment.
Area of Science:
- Pulmonology and immunology research focusing on respiratory diseases.
Background:
- Asthma is a complex lung disease with varied clinical presentations (phenotypes) and underlying mechanisms (endotypes).
- T helper type 2 (Th2) inflammation, driven by cytokines like IL-5, IL-4, and IL-13, is a primary driver in about half of mild-to-moderate and severe asthma cases.
- Non-Th2 pathways involving cytokines such as IL-17 and TNF-α, alongside inflammation-independent molecular processes, also contribute to asthma pathogenesis.
Purpose of the Study:
- To review the current understanding of asthma heterogeneity, focusing on Th2-dependent and independent mechanisms.
- To highlight newly identified molecules implicated in asthma progression.
- To discuss established and emerging biomarkers for classifying asthma endotypes.
Main Methods:
- Literature review and synthesis of recent research on asthma pathogenesis, endotypes, and biomarkers.
- Analysis of cellular and molecular mechanisms underlying different asthma subtypes.
- Evaluation of diagnostic and prognostic utility of various biomarkers.
Main Results:
- Th2 inflammation is central to many asthma cases, but non-Th2 and inflammation-independent pathways are increasingly recognized.
- Novel molecules like ORMDL3 and gasdermin B are identified as key players in inflammation-independent asthma progression.
- Biomarkers such as eosinophils, IgE, fractional exhaled nitric oxide (FeNO), and periostin are useful for Th2-high asthma, while sputum neutrophils aid in diagnosing Th2-low asthma.
Conclusions:
- Asthma is a multifaceted disease requiring a deeper understanding of its diverse endotypes.
- Further research is essential to identify novel, practical biomarkers for improved asthma diagnosis, classification, and personalized treatment strategies.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

